The role of tapasin in MHC class I antigen assembly

Immunologic Research

Volumn 20, Issue 3, 1999, Pages 79-88

  Androlewicz, Matthew J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Antigen processing; ER; MHC; TAP; Tapasin

Indexed keywords

CALRETICULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; PEPTIDE; TAPASIN; THIOL PROTEINASE; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; CELL TRANSPORT; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; PRIORITY JOURNAL;

EID: 0032721163     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02786464     Document Type: Article

References (33)

1. 1. Pamer E, Cresswell P: Mechanisms of MHC class I - restricted antigen processing. Annu Rev Immunol 1998;16:323-358.
2. 2 Salter RD, Cresswell P: Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J. 1986;142:943-949.
3. 3 DeMars R, Rudersdorf R, Chang C, Petersen J, Strandtmann J, Korn N, Sidwell B, Orr HT: Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens. Proc. Natl. Acad. Sci. USA 1985;82:8183-8187.
4. 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 1994;368: 864-867.
5. 5 Suh W-K, Chen-Doyle MF, Fruh K, Wang K, Peterson PA, Williams DB: Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 1994;264:1322-1326.
6. 6 Bergeron JJM, Brenner MB, Thomas DY, Williams DB: Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. Trends Biochem Sci. 1994;19:124-128.
7. 7 Krause K-H, Michalak M: Calreticulin. Cell 1997;88:439-443.
8. 8 Sadasivan BK, Cariappa A, Waneck GL, Cresswell P: Assembly, peptide loading, and transport of MHC class I molecules in a calnexin-negative cell line. Cold Spring Harb Symp Quant Biol 1995;60:267-275.
9. 9 Scott JE, Dawson JR: MHC class I expression and transport in a calnexin-deficient cell line. J. Immunol. 1995;155:143-148.
10. 10 Greenwood R, Shimizu Y, Sekhon GS, DeMars R: Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line. J Immunol 1994;153:5525-5536.
11. 11 Hughes EA, Cresswell P: The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex. Curr Biol 1998;8:709-712.
12. 12 Morrice NA, Powis SJ: A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr Biol 1998;8:713-716.
13. 13 Oliver JD, van der Wal FJ, Bulleid NJ, High S: Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science 1997;275:86-88.
14. 14 Otsu M, Urade R, Kito M, Omura F, Kikuchi M: A possible role of ER-60 protease in the degradation of misfolded proteins in the endoplasmic reticulum. J Biol Chem 1995;270:14958-14961.
15. 15 Jackson MR, Cohen-Doyle MF, Peterson PA, Williams DB: Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90). Science 1994;263:384-387.
16. 16 Rajagopalan S, Brenner MB: Calnexin retains unassembled major histocompatibility complex class I free heavy chains in the endoplasmic reticulum. J Exp Med 1994;180:407-412.
17. 17 Ortmann B, Copeman J, Lehner PJ, Sadasivan B, Herberg JA, Grandea AJ, Riddell SR, Tampe R, Spies T, Trowsdale J, Cresswell P: A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 1997;277:1306-1309.
18. 18 Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P: Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996;5:103-114.
19. 19 Solheim JC, Harris MR, Kindle CS, Hansen TH: Prominence of beta 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J Immunol 1997; 158:2236-2241.
20. 20 Grandea AG, Androlewicz MJ, Athwal RS, Geraghty DE, Spies T: Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 1995;270:105-108.
21. 21 Neisig A, Wubbolts R, Zang X, Melief C, Neefjes J: Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 1996;156:3196-3206.
22. 22 Li S, Sjogren H-O, Hellman U, Pettersson RF, Wung P: Cloning and functional characterization of a subunit of the transporter associated with antigen processing. Proc Natl Acad Sci USA 1997;94:8708-8713.
23. 23 Lehner PJ, Surman MJ, Cresswell P: Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line 220. Immunity 1998;8:221-231.
24. 24 Peh CA, Burrows SR, Barnden M, Khanna R, Cresswell P, Moss DJ, McCluskey J: HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 1998;8:531-542.
25. 25 Lewis JW, Sewell A, Price D, Elliott T: HLA-A *0201 presents TAP-dependent peptide epitopes to cytotoxic T lymphocytes in the absence of tapasin. Eur J Immunol 1998;28:3214-3220.
26. 26 Grandea AG, 3rd, Lehner PJ, Cresswell P, Spies T: Regulation of MHC class I heterodimer stability and interaction with TAP by tapasin. Immunogenetics 1997;46:477-483.
27. 27 Sijts AJ, Pamer EG: Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes. J Exp Med 1997;185:1403-1411.
28. 28 Lewis JW, Elliott T: Evidence for successive peptide binding and quality control stages during MHC class I assembly. Curr Biol 1998; 8:717-720.
29. 29 Peace-Brewer AL, Tussey LG, Matsui M, Li G, Quinn DG, Frelinger JA: A Point Mutation in HLA-A *0201 Results in Failure to Bind the TAP Complex and to Present Virus -Derived Peptides to CTL. Immunity 1996;4:505-514.
30. 30 Lewis JW, Neisig A, Neefjes J, Elliott T: Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP. Curr Biol 1996;6:873-883.
31. 31 Kropshofer H, Hammerling GJ, Vogt AB: How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol Today 1997;18:77-82.
32. 32 Riberdy JM, Newcomb JR, Surman JM, Barbosa JA, Cresswell P: HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 1992;360:474-477.
33. 33 Lee N, Malacko AR, Ishitani A, Chen MC, Bajorath J, Marquardt H, Geraghty DE: The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 1995;3:591-600.